Resultados de la búsqueda 931-940 of 4230 for Relapse

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  3. Ensayos clínicos - Neurología

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  4. Neurología - Ensayos clínicos

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  5. Ensayos clínicos - Neurología

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  6. Prolapso de los órganos pélvicos - Médicos y departamentos - Mayo Clinic

    Departamentos y especialidades. Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  8. Oncología (médica) - Ensayos clínicos

    A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn ...

  9. Oncología (médica) - Ensayos clínicos

    Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  10. Oncología (médica) - Ensayos clínicos

    Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...